Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT01626014

Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Making End of Life Decision in Ovarian Cancer: When to Enter Hospice? A Prototype Interactive Computer Program for Patients and Providers

Sponsor: University of Minnesota

Conditions Fallopian Tube Cancer Recurrent Ovarian Cancer Stage III Ovarian Cancer Stage IV Ovarian Cancer

Interventions Prototype System Usual Care Educational Website

Updated 7 times since 2017 Last updated: Nov 30, 2015 Started: Aug 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01626014, this EARLY_PHASE1 trial focuses on Fallopian Tube Cancer and Recurrent Ovarian Cancer and remains completed. Sponsored by University of Minnesota, it has been updated 7 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Nov 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Nov 2019 [monthly]

Completed EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States